Giles Richard Platford

CEO

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 1 saleSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€460k

Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €460k.

Filing timeline

BuySale

Giles Richard Platford

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Giles Richard Platford: trading record in brief

Giles Richard Platford is a declared insider of Takeda Pharmaceutical Co Ltd, with filings sourced from SEC (Form 4). Over a trading history stretching from 27 April 2026 to 10 August 2026, the count stands at 3 filings.

On the market, this insider has only sold: 1 sale, €460k in total. Outside the open market, there are 2 share grants.

The record was last updated on 12 August 2026 with an open-market sale (€460k) in Takeda Pharmaceutical Co Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.